Results 11 to 20 of about 7,545,643 (384)
Tuberculosis and HIV co-infection. [PDF]
Tuberculosis (TB) and HIV co-infections place an immense burden on health care systems and pose particular diagnostic and therapeutic challenges. Infection with HIV is the most powerful known risk factor predisposing for Mycobacterium tuberculosis ...
Andrzej Pawlowski +4 more
doaj +5 more sources
Tuberculosis/HIV co-infection [PDF]
Soumya Swaminathan
openalex +2 more sources
HTLV-1 and Co-infections [PDF]
Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell infection in humans, impacting the host immune response. This virus causes a range of clinical manifestations, from inflammatory conditions, including neuronal damage (HTLV-1 associated myelopathy, HAM) to life-threatening leukemia (adult T-cell leukemia, ATL). Human
Carolina Rosadas +2 more
openaire +5 more sources
Background To explore and describe the current literature surrounding bacterial/fungal co-infection in patients with coronavirus infection. Methods MEDLINE, EMBASE, and Web of Science were searched using broad based search criteria relating to ...
T. Rawson +8 more
semanticscholar +1 more source
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
Co-infections with different variants of SARS-CoV-2 are a key precursor to recombination events that are likely to drive SARS-CoV-2 evolution. Rapid identification of such co-infections is required to determine their frequency in the community ...
R. Rockett +24 more
semanticscholar +1 more source
COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis
Background and Aim: Co-infection of COVID-19 with other respiratory pathogens which may complicate the diagnosis, treatment, and prognosis of COVID-19 emerge new concern.
M. Dadashi +7 more
semanticscholar +1 more source
SARS‐CoV‐2 and dengue virus co‐infection cases have been on the rise in dengue‐endemic regions as coronavirus disease 2019 (COVID‐19) spreads over the world, posing a threat of a co‐epidemic.
Chowdhury Nusaiba Binte Sayed Prapty +8 more
semanticscholar +1 more source
Background With the easing of COVID-19 non-pharmaceutical interventions, the resurgence of both influenza and respiratory syncytial virus (RSV) was observed in several countries globally after remaining low in activity for over a year.
Bingbing Cong +3 more
semanticscholar +1 more source
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.
This study describes the prevalence of SARS-CoV-2 co-infection with noncoronavirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 2020.
David Kim +4 more
semanticscholar +1 more source
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review
Background Dengue is the most common arboviral disease in the tropical and sub-tropical regions of the world. Like other regions, dengue-endemic areas have faced the additional public health and socio-economic impact of the ongoing coronavirus disease ...
T. Tsheten +4 more
semanticscholar +1 more source

